MGNX Competitors & Alternatives
Compare MacroGenics Inc with similar stocks in the same industry
Biotechnology
MGNX
Main Stock$4.29
Tradestie Score
59
Market Cap
$107.45M
Revenue Growth
0.6%
Analyst Upside
+57.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.57
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.87
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$34.81
|
$293.03M | - | 62 | Compare |
|
OMER
Omeros Corporation
|
$10.50
|
$281.75M | 9.0 | 62 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.92
|
$275.54M | - | 60 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.85
|
$275.13M | - | 51 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.50
|
$269.08M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$39.08
|
$256.54M | - | 62 | Compare |
More MGNX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry